APOE Missense Variant Linked to Increased Alzheimer's Disease Risk in African Americans
A case-control study found that the APOE ε3[R145C] variant, seen in 4 percent of African Americans, increases AD risk in individuals with the ε3/ε4 genotype.
Late-Onset Ataxia Linked to New Repeat Expansion in FGF14 Gene
The repeat expansion appears to coincide with late-onset cerebellar ataxia risk, particularly in patients from a French-Canadian population.
Centogene to Offer Genomic Data for Rare Neurodegenerative Diseases on BC Platforms Network
The partnership will expand genomics data on the BCRquest research network by 20 percent and diversify BC Platforms' research dataset.
RetinalGenix Technologies Acquires DNA/GPS
The deal gives RetinalGenix rights to DNA/GPS's retinal imaging and genetic mapping technology for patient screening and early diagnosis.
BC Platforms Partners With Finnish Biobanks for Therapeutics Research
The company, which has its R&D center in Finland, has won a multiyear contract with three biobanks to improve access to and management of genomic and other clinical data.